LATEST
Jon Hamm, 55, says he's taking a year off work as he prepares to become a first-time dad✦Oracle's 'force majeure' notice raises questions about the company's ability to deliver on AI data centers✦There's Room For Bond Selloff To Go Further: Dunn✦US, China Relationship 'Too Big to Fail,' Says Sen. Steve Daines✦Silicon Valley's new fashion icon: Alexandr Wang and his camo t-shirt✦
Thu, Sep 24, 2026
Loading weather...
Markets

Rodman & Renshaw Initiates Coverage of Quince Therapeutics with a Buy

Fintel reports that on September 24, 2026, Rodman & Renshaw initiated coverage of Quince Therapeutics (NASDAQGS:QNCX) wi...

By Dhallo News · September 25, 2026 at 12:03 AM IST

Fintel reports that on September 24, 2026, Rodman & Renshaw initiated coverage of Quince Therapeutics (NASDAQGS:QNCX) with a Buy recommendation.Prior to this rating action, the stock's pre-action close and latest close were both recorded at $30.15 on September 23, 2026. Quinc

SOURCE: Nasdaq
ORIGINAL REPORT: Click here
DHALLO EDITORIAL STATUS: Aggregated & reviewed
Have feedback on this article?Report error or suggestion

Read More from Markets

There's Room For Bond Selloff To Go Further: Dunn

Nisha Patel, SMA Fixed Income Portfolio Manager at Parametric, and Deirdre Dunn,...

Read Article »

US, China Relationship 'Too Big to Fail,' Says Sen. Steve Daines

Republican Senator from Montana Steve Daines said that he views the relationship...

Read Article »

Nifty outlook for tomorrow: Why 23,000 matters after breaking below 4-month support? Resistance, support levels | Friday

The Nifty index broke down from an inside candle pattern, closing below the cruc...

Read Article »
Return to Front Page

5 minutes. The news that matters.

Get the most important stories of the day, without having to browse hundreds of articles.